The first prescription should come with a plan for the next conversation. Testosterone monitoring is about whether treatment is helping, whether new problems have appeared, and whether the original plan still fits your health. A higher hormone result alone cannot answer all three questions.
This guide outlines topics to discuss with the clinician who prescribes your treatment. It does not give a personal testing schedule or instructions for changing a dose. Your diagnosis, formulation, age, and other conditions affect what follow-up should include.
- Track symptom benefit and safety together.
- Know who reviews tests and responds to concerns.
- Do not adjust treatment from isolated results.
Know the baseline
Before treatment, ask which symptoms and measurements will serve as the starting point. A clear baseline helps the care team distinguish a new change from a pre-existing concern. Bring previous blood counts, blood-pressure information, and relevant specialist reports.
The Endocrine Society identifies conditions that can make starting testosterone inappropriate, including elevated hematocrit, untreated severe sleep apnea, certain prostate concerns, and recent major cardiovascular events. A clinician needs your actual history to apply that guidance.
Blood counts are a safety measure
Hematocrit describes the proportion of blood occupied by red blood cells. Testosterone can raise it, which is why a blood count is part of the safety discussion. Ask who reviews the result and how quickly you will hear about a concerning change.
Do not assume you should arrange blood donation or change your medication yourself because someone else did. The appropriate response depends on the result, symptoms, and clinical context. A portal number without interpretation is not a complete follow-up.
Include blood pressure and symptoms
FDA labeling changes in 2025 emphasized increased blood pressure with testosterone products. Let your clinician know about existing hypertension and any change in treatment for it. Ask whether home readings would be useful and how to collect them consistently.
Report new swelling, skin problems, changes in sleep, urinary symptoms, or other concerns rather than saving everything for a distant refill appointment. The point is to allow the prescriber to assess the change, not to decide from a checklist which drug caused it.
Prostate questions need context
Prostate assessment depends on age, risk, symptoms, and shared decisions about screening. A change in PSA is not automatically cancer, but it should not be casually dismissed as an expected hormone effect. The care team can decide whether repeat testing or urological evaluation is needed.
Ask how prostate-related findings will be handled and who coordinates specialist care. A telehealth service should explain the limits of what it can evaluate remotely and how an in-person referral would work.
Know when routine follow-up is not enough
New chest pain, sudden shortness of breath, or symptoms of stroke need urgent medical evaluation; do not wait for a routine portal response. For non-emergency concerns, keep the clinic’s contact process and the dispensing pharmacy’s number somewhere easy to find.
At a planned review, describe both benefit and burden. If the symptoms that motivated treatment have not meaningfully improved, ask whether the diagnosis, goals, or treatment should be reconsidered. See questions before TRT for a printable discussion list.
Sources & reading notes
Provider pages describe advertised services, not independently verified outcomes. Prices and eligibility may change. Checked September 20, 2026.